Analytical development strategies for comparator products

American Pharmaceutical Review

Volumn 6, Issue 2, 2003, Pages 92-97

  Huynh Ba, Kimloan C ^a   Aubry, Anne Françoise ^b  

^a PFIZER INC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

ACCURACY; ANALYTIC METHOD; ARTICLE; CLINICAL RESEARCH; DRUG BIOAVAILABILITY; DRUG DOSAGE FORM; DRUG MARKETING; DRUG RELEASE; DRUG RESEARCH; DRUG STABILITY; ENCAPSULATION; PRACTICE GUIDELINE; SENSITIVITY AND SPECIFICITY; STANDARD; TABLET FORMULATION; VALIDATION PROCESS;

EID: 0242332303     PISSN: 10998012     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Federal Register, September 16, 1998, 63(179), 49587.
2. Torbeck, L.D., "Preventing the Practice of Testing into Compliance. A Practical Solutions Guide", Pharmaceutical Technology 2002, 26(10), 138.
3. Perry, L., "Outsourcing Industry Leaders: Look Ahead to a Bright Future", Pharmaceutical Technology 2001, 25(1), 68.
4. Levin-Epstein, M., Miller, J., and Michalski, L., "Contract Laboratory Services 2000 Survey", BioPharm 2000, 13 (6), 14.
5. Hayes, H.B., "Auditing Your Contractor. The Human Equation", Pharmaceutical Technology 2002, 26(9), 106.
6. Miller, J., Glass, K.K., and Michalski, L., "Balancing the Benefits of Outsourcing", BioPharm 2001, 14 (1), 52.